Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8366)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2019 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: What is the best option? World J Cardiol 2019; 11(10): 221-235 [PMID: 31754410 DOI: 10.4330/wjc.v11.i10.221] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v11/i10/221.htm |
| Number | Citing Articles |
| 1 |
Isaiah K. Mensah, Humaira Gowher. Signaling Pathways Governing Cardiomyocyte Differentiation. Genes 2024; 15(6): 798 doi: 10.3390/genes15060798
|
| 2 |
Ilaria Gisone, Antonella Cecchettini, Elisa Ceccherini, Elisa Persiani, Maria Aurora Morales, Federico Vozzi. Cardiac tissue engineering: Multiple approaches and potential applications. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.980393
|
| 3 |
Jinjuan Yang, Shaoxiang Chen, Fuyu Duan, Xiuxiu Wang, Xiaoxian Zhang, Boonxuan Lian, Meng Kou, Zhixin Chiang, Ziyue Li, Qizhou Lian. Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management. Cells 2022; 11(21): 3511 doi: 10.3390/cells11213511
|
| 4 |
Saeideh Edalati, Safoura Khajeniazi. Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model. Regenerative Therapy 2022; 20: 26 doi: 10.1016/j.reth.2022.03.003
|
| 5 |
Melania Lippi, Ilaria Stadiotti, Giulio Pompilio, Elena Sommariva. Human Cell Modeling for Cardiovascular Diseases. International Journal of Molecular Sciences 2020; 21(17): 6388 doi: 10.3390/ijms21176388
|
| 6 |
M.I. Nasser, Xiao Qi, Shuoji Zhu, Yin He, Mingyi Zhao, Huiming Guo, Ping Zhu. Current situation and future of stem cells in cardiovascular medicine. Biomedicine & Pharmacotherapy 2020; 132: 110813 doi: 10.1016/j.biopha.2020.110813
|
| 7 |
Esmeralda Alonso-Barroso, Belén Pérez, Lourdes Ruiz Desviat, Eva Richard. Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia. International Journal of Molecular Sciences 2021; 22(3): 1161 doi: 10.3390/ijms22031161
|
| 8 |
A. L. Klass, M. I. Shadrina, P. A. Slominsky, E. V. Filatova. Prospects for the Use of Cell Cultures in Modeling Myocardial Diseases: Hypertrophic Cardiomyopathy. Cell and Tissue Biology 2024; 18(4): 360 doi: 10.1134/S1990519X24700305
|
| 9 |
Nerea Jimenez-Tellez, Damon Williams, Yu Liu, Mingqiang Wang, Mark Chandy, Joseph C. Wu. Transcriptomic analysis of nicotine on the cardiovascular system using a diverse population of human induced pluripotent stem cell-derived endothelial cells. Journal of Molecular and Cellular Cardiology 2025; 198: 21 doi: 10.1016/j.yjmcc.2024.11.001
|
| 10 |
Mohamed M. Bekhite, P. Christian Schulze. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective. Cells 2021; 10(12): 3483 doi: 10.3390/cells10123483
|
| 11 |
Takahiro Iwamiya, Bertrand-David Segard, Yuimi Matsuoka, Tomomi Imamura, Vincenzo Lionetti. Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis. PLOS ONE 2020; 15(9): e0237810 doi: 10.1371/journal.pone.0237810
|
| 12 |
Rafael Dariolli, Chiara Campana, Amy Gutierrez, Eric A. Sobie. In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic “COVID-19 Cardiomyocyte”. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.624185
|
| 13 |
Xin-Yi Wu, Yee-Ki Lee, Yee-Man Lau, Ka-Wing Au, Yiu-Lam Tse, Kwong-Man Ng, Chun-Ka Wong, Hung-Fat Tse. The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals 2024; 17(8): 1030 doi: 10.3390/ph17081030
|
| 14 |
Keyang Zhu, Xiaoming Bao, Yingchao Wang, Ting Lu, Ling Zhang. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery. Biomedicine & Pharmacotherapy 2023; 157: 113970 doi: 10.1016/j.biopha.2022.113970
|
| 15 |
Adéla Krajčová, Vlasta Němcová, Milada Halačová, Petr Waldauf, Martin Balík, František Duška. Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells. Toxicology and Applied Pharmacology 2023; 477: 116676 doi: 10.1016/j.taap.2023.116676
|
| 16 |
Nazanin Vaziri, Diogo Marques, Steven C. Greenway, Chad A. Bousman. The cellular mechanism of antipsychotic-induced myocarditis: A systematic review. Schizophrenia Research 2023; 261: 206 doi: 10.1016/j.schres.2023.09.039
|
| 17 |
Magali Seguret, Eva Vermersch, Charlène Jouve, Jean-Sébastien Hulot. Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies. Biomedicines 2021; 9(5): 563 doi: 10.3390/biomedicines9050563
|
| 18 |
Cátia D. Correia, Anita Ferreira, Mónica T. Fernandes, Bárbara M. Silva, Filipa Esteves, Helena S. Leitão, José Bragança, Sofia M. Calado. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?. Cells 2023; 12(13): 1727 doi: 10.3390/cells12131727
|